SpringWorks Therapeutics
Developing precision medicines for rare diseases and cancer
- B2B
About SpringWorks Therapeutics
The company is a biopharmaceutical firm focused on developing targeted oncology medicines for severe rare diseases and cancer using precision medicine
Key facts
- Industry
- Biotechnology Research
- Company size
- 251–1,000 employees
- Headquarters
- Stamford, Connecticut, United States
- Founded
- 2017
- Revenue
- $192MFY2024, publicly reported
- Website
- springworkstx.com
SpringWorks Therapeutics at a glance
SpringWorks Therapeutics is a B2B company in the Biotechnology Research industry, headquartered in Stamford, Connecticut, United States.
SpringWorks Therapeutics was founded in 2017.
SpringWorks Therapeutics has 251–1,000 employees.
SpringWorks Therapeutics's revenue is $192M (FY2024, publicly reported).
Frequently asked questions about SpringWorks Therapeutics
What is SpringWorks Therapeutics's revenue?
SpringWorks Therapeutics's revenue is $192M (FY2024, publicly reported).
How many employees does SpringWorks Therapeutics have?
SpringWorks Therapeutics has 251–1,000 employees.
Where is SpringWorks Therapeutics headquartered?
SpringWorks Therapeutics is headquartered in Stamford, Connecticut, United States.
Selling to companies like SpringWorks Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies